Skip to main content
Log in

Intraperitoneal immunity and pneumoperitoneum

  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background: Carbon dioxide (CO2) pneumoperitoneum has been implicated as a possible factor in depressed intraperitoneal immunity. Using in vitro functional assays, CO2 has been shown to decrease the function of peritoneal macrophages harvested from insufflated mice. However, an effective in vivo assessment is lacking. Listeria monocytogenes (LM), an intracellular pathogen, has served as a well-established in vivo model to study cell-mediated immune responses in mice. This study examines the immune competence of mice based on their ability to clear intraperitoneally administered LM following CO2 vs helium (He) insufflation.

Methods: Eighty-five mice (C57Bl/6, males, 4–6 weeks old) were divided between the following four treatment groups: CO2 insufflation, He insufflation, abdominal laparotomy (Lap), and control (anesthesia only). Immediately postoperatively, each group was inoculated percutaneously and intraperitoneally with a sublethal dose (.015 × 106 org) of virulent LM (EGD strain). Half of the animals were killed on postoperative day 3 and half on day 5. Spleens and livers (sites of bacterial predilection) were harvested, homogenized, and plated on TSB agar. The amount of bacteria (1 × 106 LM/spleen and liver) from each group was then compared. Statistical significance was set at p≤ 0.05.

Results: Control animals had nominal bacteria on day 3 (0.016 × 106 LM/spleen and liver), and the bacterial burden remained low at day 5 (0.038 × 106 LM/spleen and liver) postchallenge. On day 3, the bacterial burden was significantly higher in the CO2 group (5.46 × 106 LM/spleen and liver) as compared to He (0.093 × 106 LM/spleen and liver) and controls. The Lap group (3.44 × 106 LM/spleen and liver) had significantly more bacteria than the controls. There were no significant differences between any of the groups on day 5.

Conclusions: In this animal model, CO2 pneumoperitoneum impaired cell-mediated intraperitoneal immunity significantly more than He pneumoperitoneum and controls on day 3. Also on day 3, laparotomy caused impairment of intraperitoneal immunity when compared to controls. Finally, intraperitoneal immunosuppression resolved by day 5.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 22 July 1998/Accepted: 3 March 1999

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chekan, E., Nataraj, C., Clary, E. et al. Intraperitoneal immunity and pneumoperitoneum. Surg Endosc 13, 1135–1138 (1999). https://doi.org/10.1007/s004649901189

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004649901189

Navigation